Neha Atyam
Foot & Ankle Surgery · Princeton, NJNPI 1457914814
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $14,246 with a category attached, or 70.2%. Arthrex accounts for 77.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $12,619 and has fallen 93.6% since, to $803 in 2025. Among foot & ankle surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $226.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$11K
- Stryker$2K
- Kerecis Limited$404
- Averitas Pharma Inc.$324
- Seapearl East, Inc$150
- Novus Surgical Consultants$126
- plus $290 from 6 others
What the payments were for
- Grants$10,00070%
- Travel & lodging$2,15715%
- Food & beverage$2,08915%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 15 | $11,055 |
| Stryker | 18 | $1,898 |
| Kerecis Limited | 6 | $404 |
| Averitas Pharma Inc. | 8 | $324 |
| Seapearl East, Inc | 1 | $150 |
| Novus Surgical Consultants | 3 | $126 |
| Convatec Inc. | 4 | $102 |
| Paratek Pharmaceuticals, Inc. | 3 | $74 |
| Organogenesis Inc. | 2 | $51 |
| Next Science LLC | 1 | $30 |
| Orthofix Medical, Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$1,372
- PROstep$1,139
- SALVATION$596
- ORTHOLOC 2 LAPIFUSE$596
- PROPHECY$596
- Kerecis GraftGuide$343
- HOFFMANN$154
- Qutenza$125
- CITREFIX$110
How this compares
$14,246 in reported general payments places this provider in the 90th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 23 | $459 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $124 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Princeton
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$843K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Mark SolomonCedar Knolls$232K
- Evan AdlerOld Bridge$195K
- Shane HollawellManasquan$169K
- Jacob ReinkrautRidgewood$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.